We are live on ! Find out more
NM

Newtyn Management Portfolio holdings

AUM $936M
1-Year Est. Return 27.23%
This Fund
S&P 500
This Quarter Est. Return
+16.98%
1 Year Est. Return
+27.23%
3 Year Est. Return
+51.99%
5 Year Est. Return
+55.23%
10 Year Est. Return
+165.15%
AUM
$485M
AUM Growth
+$29.1M
Cap. Flow
-$15.4M
Cap. Flow %
-3.18%
Top 10 Hldgs %
51.57%
Holding
81
New
1
Increased
35
Reduced
19
Closed
10

Top Buys

Rank Stock Value
1
PPLI
People Inc
PPLI
+$20.7M
2
AMBP icon
Ardagh Metal Packaging
AMBP
+$4.55M
3
SAFE
Safehold
SAFE
+$4.08M
4
FLWS icon
1-800-Flowers.com
FLWS
+$3.62M
5
DXLG icon
Destination XL Group
DXLG
+$3.4M

Top Sells

Rank Stock Value
1
SLVM icon
Sylvamo
SLVM
+$14.9M
2
TBPH icon
Theravance Biopharma
TBPH
+$11M
3
AVTA
Avantax, Inc. Common Stock
AVTA
+$6.33M
4
VRTS icon
Virtus Investment Partners
VRTS
+$5.09M
5
PCG icon
PG&E
PCG
+$4.25M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.15%
2 Healthcare 21.39%
3 Financials 12.53%
4 Real Estate 9.47%
5 Communication Services 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHAT icon
26
Phathom Pharmaceuticals
PHAT
$708M
$5.43M 1.12%
484,074
+168,099
+53% +$1.73M
TLYS icon
27
Tilly's
TLYS
$116M
$4.95M 1.02%
547,463
-23,687
-4% -$208K
PCG icon
28
PG&E
PCG
$38.3B
$4.37M 0.9%
268,921
-281,079
-51% -$4.25M
CUBI icon
29
Customers Bancorp
CUBI
$2.66B
$4.25M 0.88%
150,000
– –
WVE icon
30
Wave Life Sciences
WVE
$1.09B
$4.2M 0.87%
600,000
– –
SFIX
31
Stitch Fix
SFIX
$536M
$4.03M 0.83%
1,295,000
+365,800
+39% +$1.37M
ETNB
32
DELISTED
89bio
ETNB
$3.95M 0.81%
310,000
– –
ASTL icon
33
Algoma Steel
ASTL
$406M
$3.75M 0.77%
590,899
– –
IVAC
34
DELISTED
Intevac Inc
IVAC
$3.36M 0.69%
520,000
– –
NXDT
35
NexPoint Diversified Real Estate Trust
NXDT
$234M
$2.8M 0.58%
250,000
– –
COLL icon
36
Collegium Pharmaceutical
COLL
$1.15B
$2.44M 0.5%
105,000
– –
PYXS icon
37
Pyxis Oncology
PYXS
$168M
$2.01M 0.41%
1,500,000
+700,000
+88% +$1.05M
FTH
38
Faeth Therapeutics
FTH
$702M
$1.72M 0.36%
57,778
+37,028
+178% +$1.09M
CYT
39
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$1.68M 0.35%
1,020,000
+365,888
+56% +$587K
ATAI icon
40
AtaiBeckley Inc
ATAI
$2.66B
$1.6M 0.33%
600,000
+130,000
+28% +$395K
BOLT icon
41
Bolt Biotherapeutics
BOLT
$7.67M
$1.5M 0.31%
57,500
+27,500
+92% +$754K
DNMR
42
DELISTED
Danimer Scientific, Inc.
DNMR
$1.43M 0.3%
20,000
+4,375
+28% +$414K
ALGS icon
43
Aligos Therapeutics
ALGS
$26.2M
$1.43M 0.3%
60,000
+20,000
+50% +$504K
IVVD icon
44
Invivyd
IVVD
$158M
$1.35M 0.28%
900,000
+550,000
+157% +$1.53M
ALEC icon
45
Alector
ALEC
$168M
$1.34M 0.28%
145,000
+40,000
+38% +$349K
SIOX
46
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1.3M 0.27%
3,000,000
+1,500,000
+100% +$487K
ORKA
47
Oruka Therapeutics
ORKA
$5.82B
$1.27M 0.26%
44,857
+3,190
+8% +$81.8K
PASG icon
48
Passage Bio
PASG
$14.4M
$1.09M 0.23%
39,500
+24,500
+163% +$618K
TCRR
49
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$1.07M 0.22%
1,075,000
+475,000
+79% +$640K
LTCH
50
DELISTED
Latch, Inc. Common Stock
LTCH
$1.06M 0.22%
1,490,000
+490,000
+49% +$449K
1
2
3 4

Similar funds

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PWAM
Private Wealth Asset Management Cedar Rapids, Iowa $935M AUM 17.66% 1-Year Est. Return
NI
NetEase Inc Hangzhou, China $934M AUM 11.31% 1-Year Est. Return
MCM
Massar Capital Management Stamford, Connecticut $934M AUM 14.18% 1-Year Est. Return
TS
Tamar Securities Woodland Hills, California $934M AUM 26.74% 1-Year Est. Return
TW
TritonPoint Wealth Chevy Chase, Maryland $934M AUM 23.95% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
FPI
Financial Plan Inc Bellingham, Washington $933M AUM

Newtyn Management's Q4 2022 Portfolio in Review

As of Q4 2022, Newtyn Management held 81 positions worth $485M, up 6.4% from $455M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Newtyn Management withdrew a net $15.4M in Q4 2022, closing 10 positions and reducing 19 holdings. Its most notable exit was Sylvamo, an estimated $14.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Newtyn Management opened a new position in EUDA Health Holdings worth $33.4K.

  • Newtyn Management's largest Q4 2022 buy was EUDA Health Holdings: 1,000 shares worth $33.4K.
  • Newtyn Management added most to People Inc in Q4 2022, an estimated $20.7M increase.
  • Newtyn Management's biggest Q4 2022 reduction was Theravance Biopharma, cutting an estimated $11M.
  • Newtyn Management fully exited Sylvamo in Q4 2022, selling an estimated $14.9M.
  • Newtyn Management's ten largest holdings make up 52% of its $485M portfolio in Q4 2022.
  • Newtyn Management opened 1 new position and closed 10 in Q4 2022.
  • Newtyn Management's portfolio value rose 6.4% quarter-over-quarter to $485M.

Based on Newtyn Management's 13F filing for Q4 2022, filed 14 Feb 2023.